The deal, which was for $125 million according to sources close to the matter, is Automattic's second acquisition of a cross-platform messaging solution.
This is a Theranos level of fake it till you make it: lie about where the product is used, who approves it and how well it works and hope the reality catches up quicker than clients.
It's pretty clear the technology is not ready for this, and once again regulators and prosecutors won't move a finger to prevent potential harm.